<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0155157</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3696</journal-id>
<journal-id journal-id-type="nlm-ta">FEBS Lett</journal-id>
<journal-id journal-id-type="iso-abbrev">FEBS Lett.</journal-id>
<journal-title-group>
<journal-title>FEBS letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">0014-5793</issn>
<issn pub-type="epub">1873-3468</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28796901</article-id>
<article-id pub-id-type="pmc">5856336</article-id>
<article-id pub-id-type="doi">10.1002/1873-3468.12788</article-id>
<article-id pub-id-type="manuscript">EMS76432</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>From peroxisomal disorders to common neurodegenerative diseases – the role of ether phospholipids in the nervous system</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dorninger</surname>
<given-names>Fabian</given-names>
</name>
<xref ref-type="fn" rid="FN3">iD</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Forss-Petter</surname>
<given-names>Sonja</given-names>
</name>
<xref ref-type="fn" rid="FN4">iD</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Berger</surname>
<given-names>Johannes</given-names>
</name>
<xref ref-type="fn" rid="FN5">iD</xref>
</contrib>
<aff id="A1">Department of Pathobiology of the Nervous System, Center for Brain Research, Medical University of Vienna, Austria</aff>
</contrib-group>
<author-notes>
<corresp id="CR1"><bold>Correspondence</bold>: J. Berger, Department of Pathobiology of the Nervous System, Center for Brain Research, Medical University of Vienna, Spitalgasse 4, 1090 Vienna, Austria, Fax: +43 1 40160 934203, Tel: +43 1 40160 34300, <email>johannes.berger@meduniwien.ac.at</email></corresp>
<fn fn-type="edited-by" id="FN1">
<p id="P1">Edited by Wilhelm Just</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>28</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>3</month>
<year>2018</year>
</pub-date>
<volume>591</volume>
<issue>18</issue>
<fpage>2761</fpage>
<lpage>2788</lpage>
<!--elocation-id from pubmed: 10.1002/1873-3468.12788-->
<abstract>
<p id="P2">The emerging diverse roles of ether (phospho)lipids in nervous system development and function in health and disease are currently attracting growing interest. Plasmalogens, a subgroup of ether lipids, are important membrane components involved in vesicle fusion and membrane raft composition. They store polyunsaturated fatty acids and may serve as antioxidants. Ether lipid metabolites act as precursors for the formation of glycosyl-phosphatidyl-inositol anchors; others, like platelet-activating factor, are implicated in signaling functions. Consolidating the available information, we attempt to provide molecular explanations for the dramatic neurological phenotype in ether lipid-deficient human patients and mice by linking individual functional properties of ether lipids with pathological features. Furthermore, recent publications have identified altered ether lipid levels in the context of many acquired neurological disorders including Alzheimer’s disease (AD) and autism. Finally, current efforts to restore ether lipids in peroxisomal disorders as well as AD are critically reviewed.</p>
</abstract>
<kwd-group>
<kwd>autism</kwd>
<kwd>peroxisome</kwd>
<kwd>plasmalogen</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>